| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
Ac-DL-Trp-OH is classified as an endogenous metabolite. It has been studied for its possible anti-inflammatory and antinociceptive activities. The compound also shows bioactivity in assays for delayed death inhibitors of the malarial parasite plastid. Its targets are not fully defined but are related to its role as a metabolite and potential immunomodulator.
|
|---|---|
| ln Vitro |
In vitro, Ac-DL-Trp-OH has been evaluated for its anti-inflammatory and antinociceptive activities. It has also been tested in primary qHTS assays for delayed death inhibitors of the malarial parasite plastid, showing potency at 7375.3 nM and 14715.7 nM. These findings suggest potential antiparasitic activity.
|
| ln Vivo |
In vivo, Ac-DL-Trp-OH is an endogenous metabolite and is not administered as a therapeutic agent. Its role in the body is related to tryptophan metabolism. The compound may have physiological functions related to immune regulation and neurotransmitter synthesis.
|
| Enzyme Assay |
Cell-free assays for Ac-DL-Trp-OH are not well defined, as the compound is primarily studied as a metabolite. It can be used as a standard in analytical chemistry for the quantification of N-acetyltryptophan in biological samples.
|
| Cell Assay |
In vitro cellular assays for Ac-DL-Trp-OH involve treating cells with the compound and measuring its effects on inflammation or parasite growth. The compound's anti-inflammatory activity can be assessed by measuring cytokine production in immune cells.
|
| Animal Protocol |
In vivo animal studies for Ac-DL-Trp-OH are not typically performed, as the compound is not a drug candidate. However, its role as a metabolite may be studied in animal models of tryptophan metabolism or immune function.
|
| ADME/Pharmacokinetics |
The pharmacokinetics of Ac-DL-Trp-OH are expected to be similar to those of tryptophan. As an N-acetylated amino acid, it may be metabolized by deacetylases to release tryptophan. The compound is likely to be absorbed and distributed throughout the body.
|
| Toxicity/Toxicokinetics |
Ac-DL-Trp-OH is an endogenous metabolite and is not associated with significant toxicity. It is considered safe at physiological concentrations. Standard laboratory safety practices apply when handling the compound.
|
| Additional Infomation |
N-acetyltryptophan is an N-acetyl amino acid and an N-acetyl derivative of tryptophan. It is a metabolite. It is both an N-acetyl amino acid and a derivative of tryptophan. It is the conjugate acid of N-acetyltryptophan. N-acetyl-DL-tryptophan has been reported to be detected in Penicillium commune, soybean (Glycine max), and other organisms with relevant data.
Ac-DL-Trp-OH is a research compound with no clinical applications or regulatory approvals. It is primarily used as a standard in analytical chemistry and as a tool for studying tryptophan metabolism and immune function. Its potential anti-inflammatory and antinociceptive activities make it a subject of interest in pharmacological research. |
| Molecular Formula |
C13H14N2O3
|
|---|---|
| Molecular Weight |
246.26
|
| Exact Mass |
246.1
|
| CAS # |
87-32-1
|
| PubChem CID |
2002
|
| Appearance |
White to off-white solid powder
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
586.6±45.0 °C at 760 mmHg
|
| Melting Point |
204-206 °C (dec.)(lit.)
|
| Flash Point |
308.6±28.7 °C
|
| Vapour Pressure |
0.0±1.7 mmHg at 25°C
|
| Index of Refraction |
1.645
|
| LogP |
0.7
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
18
|
| Complexity |
332
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O
|
| InChi Key |
DZTHIGRZJZPRDV-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C13H14N2O3/c1-8(16)15-12(13(17)18)6-9-7-14-11-5-3-2-4-10(9)11/h2-5,7,12,14H,6H2,1H3,(H,15,16)(H,17,18)
|
| Chemical Name |
2-acetamido-3-(1H-indol-3-yl)propanoic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 100 mg/mL (406.07 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (10.15 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (10.15 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (10.15 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.0607 mL | 20.3037 mL | 40.6075 mL | |
| 5 mM | 0.8121 mL | 4.0607 mL | 8.1215 mL | |
| 10 mM | 0.4061 mL | 2.0304 mL | 4.0607 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
